Mirae Asset Global Investments
PPH icon

Mirae Asset Global Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Mirae Asset Global Investments’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
+3,830
New +$396K ﹤0.01% 1011
2025
Q4 		– Sell
-3,210
Closed -$290K – 1724
2025
Q3 		$290K Buy
+3,210
New +$281K ﹤0.01% 1082
2024
Q4 		– Sell
-248,473
Closed -$23.6M – 1653
2024
Q3 		$23.6M Buy
248,473
+84,273
+51% +$8M 0.1% 151
2024
Q2 		$15.1M Buy
164,200
+149,710
+1,033% +$13.4M 0.08% 191
2024
Q1 		$1.31M Buy
+14,490
New +$1.27M ﹤0.01% 1394

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Mirae Asset Global Investments's PPH Position: Q2 2026 in Review

Mirae Asset Global Investments opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 3,830 shares worth $419K. The stake represents ﹤0.01% of the portfolio and ranks #1011 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in PPH as recently as Q3 2025.

Mirae Asset Global Investments first reported a position in PPH in Q1 2024 and has held it in 5 quarters since. The position peaked at $23.6M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Mirae Asset Global Investments held 3,830 shares of VanEck Pharmaceutical ETF worth $419K as of Q2 2026.
  • VanEck Pharmaceutical ETF was a new Mirae Asset Global Investments position in Q2 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1011 holding.
  • Mirae Asset Global Investments first reported a position in VanEck Pharmaceutical ETF in Q1 2024 and has held it in 5 quarters since.
  • Mirae Asset Global Investments's VanEck Pharmaceutical ETF position peaked at $23.6M in Q3 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.